Evaluation of Cancer Cell Lines by Four-Point Probe Technique, by Impedance Measurements in Various Frequencies.
Georgia PaivanaDimitris BarmpakosSophie S MavrikouAlexandros KallergisOdysseus TsakiridisGrigoris KaltsasSpyridon KintziosPublished in: Biosensors (2021)
Cell-based biosensors appear to be an attractive tool for the rapid, simple, and cheap monitoring of chemotherapy effects at a very early stage. In this study, electrochemical measurements using a four-point probe method were evaluated for suspensions of four cancer cell lines of different tissue origins: SK-N-SH, HeLa, MCF-7 and MDA-MB-231, all for two different population densities: 50 K and 100 K cells/500 μL. The anticancer agent doxorubicin was applied for each cell type in order to investigate whether the proposed technique was able to determine specific differences in cell responses before and after drug treatment. The proposed methodology can offer valuable insight into the frequency-dependent bioelectrical responses of various cellular systems using a low frequency range and without necessitating lengthy cell culture treatment. The further development of this biosensor assembly with the integration of specially designed cell/electronic interfaces can lead to novel diagnostic biosensors and therapeutic bioelectronics.
Keyphrases
- early stage
- single cell
- cell cycle arrest
- gold nanoparticles
- quantum dots
- breast cancer cells
- induced apoptosis
- emergency department
- cell death
- squamous cell
- drug delivery
- label free
- mesenchymal stem cells
- squamous cell carcinoma
- oxidative stress
- mass spectrometry
- computed tomography
- magnetic resonance
- cell proliferation
- young adults
- cancer therapy
- combination therapy
- sentinel lymph node
- ionic liquid
- lymph node metastasis